Shuichi Kamijima

3PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Oct 17, 2022
Incidence of gastrointestinal perforation associated with bevacizumab in combination with neoadjuvant chemotherapy as first-line treatment of advanced ovarian, fallopian tube, or peritoneal cancer: analysis of a Japanese healthcare claims database.

Akihiko Ueda, Hidemichi Watari, Masaki Mandai

|Jun 27, 2022
Incidence of fistula occurrence in patients with cervical cancer treated with bevacizumab: data from real-world clinical practice.

Toru Sugiyama, Noriyuki Katsumata, Takafumi Toita

|Jun 26, 2018
Quantitative evaluation of the relative apparent diffusion coefficient values on multiparametric magnetic resonance imaging to predict higher Gleason score prostate cancer.

Seiji Kato, Shuichi Kamijima, Tsutomu Inaoka

Pageof 1

Frequent Collaborators

1 joint publications

Toru Sugiyama

1 joint publications

Noriyuki Katsumata

1 joint publications

Takafumi Toita

1 joint publications

Masako Ura